Inqu
by Isto Technologies, Inc. 2 variants
510(k) K071428
Inqu is a Class II device made by Isto Technologies, Inc., cleared under FDA 510(k) K071428 on 17 Sep 2007, active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK071428 | Date17 Sep 2007 | StatusActive |
Official records
- FDA 510(k) database K071428
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- MQV
- Device class
- Class II
- Regulation
- 21 CFR Part 888.3045
- Advisory committee
- Orthopedic
- FDA decision
- SESE Substantially Equivalent
Devices cleared under K071428
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| InQu Granules 30cc IQSP-GR-130 | IQSP-GR-130 / IQSP-GR-130 | M896IQSPGR1300 | — | On the market |
| InQu Matrix 5x10cm IQSP-MX-150 | IQSP-MX-150 / IQSP-MX-150 | M896IQSPMX1500 | — | On the market |
| InQu Matrix 5x5cm IQSP-MX-125 | IQSP-MX-125 / IQSP-MX-125 | M896IQSPMX1250 | — | On the market |
Similar devices
Other devices filed under FDA product code MQV (Filler, Bone Void, Calcium Compound).
- Signify Bioactive by GLOBUS MEDICAL, INC.
- Synthetic Bone Graft (TriPore HA, TriPore BP90, TriPore BP15) by ORTHOGEM LTD
- Fortross Bone Void Filler by Pioneer Surgical Technology, Inc.
- Osteo-P Bone Graft Substitute by MOLECULAR MATRIX
- DSM Biomedical Calcium Phosphate Cement with Microspheres by Kensey Nash Corporation Dba Dsm Biomedical
- BonAlive Granules by Bonalive Biomaterials, Ltd.
- Confirm Bioactive by GLOBUS MEDICAL, INC.
- MBCP by BIOMATLANTE
- Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix by COLLAGEN MATRIX, INC.
- Mg OSTEOREVIVE™ by BONE SOLUTIONS, INC.